United States

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

23 Jan 2017
Change (% chg)

-19.50 (-1.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale
Thursday, 29 Sep 2016 02:54am EDT 

Glaxosmithkline Plc :Gross proceeds of Aspen transaction are equivalent to £477 million.  Full Article

GSK says to sell remaining stake in Aspen Pharmacare
Wednesday, 28 Sep 2016 11:19am EDT 

GlaxoSmithKline Plc : GSK intends to sell remaining holding in Aspen . Intends to sell its remaining stake in Aspen Pharmacare Holdings Ltd . Offer price will be determined by means of an accelerated bookbuild offering process which is to start immediately .Offering is expected to comprise up to 28.2 million Aspen ordinary shares equivalent to 6.2 pct of Aspen's ordinary share capital.  Full Article

Oncodesign to buy François Hyafil research centre from GSK
Wednesday, 28 Sep 2016 01:30am EDT 

Oncodesign Sa : GSK and oncodesign have signed an agreement for Oncodesign to acquire François Hyafil research centre from GSK . Agreement is expected to become unconditional and effective by or on 1st December 2016 .Under terms of agreement, GSK will provide eur 35 million support over a four year period.  Full Article

GSK, Oncodesign announce agreement for Oncodesign's Acquisition of GSK's Research Centre in France
Wednesday, 28 Sep 2016 01:30am EDT 

Oncodesign SA : Says GSK will provide EUR35 million support over a four year period . To use funding to integrate site, its capabilities into its business and ensure continued employment of transferring staff over the period .GSK, Oncodesign announce agreement for Oncodesign's acquisition of GSK's research centre in France.  Full Article

Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis
Friday, 23 Sep 2016 08:00am EDT 

Janssen Biotech Inc:Janssen submits application seeking approval of sirukumab in United States for rheumatoid arthritis.  Full Article

GSK files regulatory submissions in U.S. and Europe for lupus drug
Friday, 23 Sep 2016 04:44am EDT 

Glaxosmithkline Plc : GSK announces regulatory submissions for subcutaneous formulation of Benlysta (Belimumab) for patients with systemic lupus disease . Has filed regulatory submissions in US and Europe for Benlysta(Belimumab) . Regulatory filings in other countries are planned during course of 2016 and 2017 Further company coverage: [GSK.L] (Bengaluru Newsroom: +91 80 6749 1136).  Full Article

GSK presents positive results from phase III FULFIL study
Tuesday, 6 Sep 2016 09:45am EDT 

GlaxoSmithKline Plc : Gsk presents positive results from phase iii fulfil study of closed triple combination therapy ff/umec/vi versus symbicort® turbohaler® in copd at ers international congress . Study which reported headline results in june 2016, met its two co-primary endpoints .Plans are on schedule for regulatory submissions of closed triple combination therapy for copd in us and europe by end of 2016.  Full Article

GlaxoSmithKline sees positive results from COPD Salford Lung study
Monday, 5 Sep 2016 02:00am EDT 

Glaxosmithkline Plc : Positive results from the copd salford lung study . Announce positive results from copd salford lung study published in nejm and presented at european respiratory congress .Results from sls provide robust evidence that will enable healthcare community to begin to understand how choice of copd treatment can significantly influence patient outcomes..  Full Article

DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market
Friday, 2 Sep 2016 11:32am EDT 

Dr.Reddy's Laboratories Ltd :Launch of bupropion hcl extended-release tablets, usp (sr) in u.s. Market.  Full Article

GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada
Wednesday, 31 Aug 2016 05:09pm EDT 

GlaxoSmithKline Plc : GSK Consumer Healthcare - Approval of flonase allergy relief for over the counter use in Canada .GSK Consumer Healthcare - Flonase allergy relief will be available over the counter in early 2017.  Full Article

PRESS DIGEST- British Business - Jan 20

Jan 20 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.